Is the integration of multiple omics, eg. genomics, transcriptomics, proteomics, and neuroimaging a more useful biomarker discovery strategy, than a single omics approach for disorders of the nervous system?
Is the integration of multiple omics, eg. genomics, transcriptomics, proteomics, and neuroimaging a more useful biomarker discovery strategy, than a single omics approach for disorders of the nervous system?